CONMED  logo
CNMDCONMED
Trade CNMD now
CONMED  primary media

About CONMED

CONMED (NYSE:CNMD) focuses on medical technology with a wide range of products geared towards surgery and patient monitoring. It's traded on the New York Stock Exchange under the ticker symbol NYSE:CNMD. Specializing in both single-use and reusable surgical devices, CONMED's portfolio includes electrosurgical systems, endoscopic technologies, and orthopedic arthroscopy equipment. The company’s projects often revolve around developing innovative solutions that improve clinical outcomes for patients and enhance the capabilities of healthcare professionals globally. CONMED aims to continue expanding its product line through research and development, as well as strategic acquisitions, to cater to the evolving needs of the medical community while maintaining high standards of quality and safety.

What is CNMD known for?

Snapshot

Public US
Ownership
1970
Year founded
4100
Employees
Utica, United States
Head office
1 of 4
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Produtos e/ou serviços de CONMED

  • Surgical devices and equipment for minimally invasive procedures, enhancing operational efficiency and patient outcomes.
  • Orthopedic surgery tools, specializing in sports medicine and reconstructive technologies.
  • Advanced patient monitoring systems, ensuring precise vital signs monitoring during surgical procedures.
  • Electrosurgical units and accessories, offering precision and control for various surgical applications.
  • Endoscopic technologies, providing innovative solutions for gastrointestinal and pulmonary diagnosis and procedures.
  • Biomedical research and development services, focused on creating cutting-edge medical devices and technologies.

equipe executiva do CONMED

  • Mr. Patrick J. BeyerPresident, CEO & Director
  • Mr. Todd W. Garner CPAExecutive VP of Finance & CFO
  • Mr. Peter K. ShagoryExecutive Vice President of Strategy & Corporate Development
  • Mr. Curt R. HartmanSpecial Advisor
  • Mr. Brent LalomiaExecutive VP of Regulatory Affairs, Quality Assurance, Clinical Affairs, & Commercial Operations
  • Mr. Andrew MollerPrincipal Accounting Officer, VP & Corporate Controller
  • Mr. Richard GlazeChief Information Officer
  • Ms. Hollie K. FoustExecutive VP, General Counsel & Corporate Secretary
  • Mr. John FerrellExecutive Vice President of Human Resources
  • Ms. Shanna L. Cotti-OsmanskiExecutive VP of Information Technology & CIO

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.